Ann Arbor.com write-up on AlertWatch
Here’s a nice article on AlertWatch in our local newspaper / online journal:
http://www.annarbor.com/business-review/alertwatch-ann-arbor-startup-raises-money-fda-approval/
Here’s a nice article on AlertWatch in our local newspaper / online journal:
http://www.annarbor.com/business-review/alertwatch-ann-arbor-startup-raises-money-fda-approval/
AlertWatch:OR and AlertWatch:OB are FDA 510(k)-cleared for sale in the United States, and are intended for use by clinicians for secondary monitoring of patients . AlertWatch accomplishes this by aggregating data from a multitude of sources and displaying them at a central location. Once alerted, the clinician must refer to the primary monitoring device before making a clinical decision.
AlertWatch:ICU, AlertWatch:AC, and AlertWatch:PACU are pending FDA clearance and are currently only available for IRB-sponsored research. Some images and interfaces are enhanced for clarity.